
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. (OCUL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OCUL · as of Jun 8, 2026
Key Statistics
Explore Ocular Therapeutix, Inc. Data
ocul stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 89.5%
The OCUL analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $30.00, representing +260.47% upside from the current price of $8.32.
Competitors & Peers
ocul competitorsStock Performance
Full HistoryAbout Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrog…
what is ocular therapeutix, inc. · ocul stock overview · ocular therapeutix, inc. company profile · who is ocular therapeutix, inc. ceo · ocul NASDAQ · ocular therapeutix, inc. headquarters · ocular therapeutix, inc. business segments
About Stock Overview & Key Data
Ocular Therapeutix, Inc. (OCUL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 25, 2014. As of the latest trading session, OCUL stock price is $8.32, with a market capitalization of $1.8B. The stock has returned -7.02% over the past 12 months and -31.84% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Ocular Therapeutix, Inc. stock is Buy, with an average 12-month price target of $30.00. In fiscal year 2025, Ocular Therapeutix, Inc. reported revenue of $51.8M and net income of -$265.9M. For detailed data — including Ocular Therapeutix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ocular Therapeutix, Inc. (OCUL) stock price is $8.32. The stock is traded on NASDAQ under the ticker symbol OCUL. The 52-week range is $6.23 – $16.44.